Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Omega-3s help eyes

This article was originally published in The Tan Sheet

Executive Summary

Results of a study coming in the July Nature Medicine show omega-3s protect against the development and progression of retinopathy - a deterioration of the retina - in mice, the National Institutes of Health announce June 24. The study shows a higher level of omega-3s reduced retinopathy by 50%. The researchers say the study has implications for premature infants, in whom retinopathy is found, and for people suffering from age-related macular degeneration. A 2006 Archives of Ophthalmology study found omega-3s could prevent AMD (1"The Tan Sheet" July 17, 2006, p. 9). The National Eye Institute is conducting the Age-Related Eye Disease Study 2 in part to assess omega-3s' effect on AMD. The Children's Hospital Boston will also test the effects of omega-3s on infants...

You may also be interested in...

High Omega-3 Intake Protective Against Age-Related Macular Degeneration

A higher intake of omega-3 fatty acids (median of .35 g/day) could have prevented an estimated 22% of the cases of age-related macular degeneration (AMD) in a recent study, according to the study's authors

EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments

While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.

US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing

The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts